JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsu, M. H.
Right arrow Articles by Prossnitz, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsu, M. H.
Right arrow Articles by Prossnitz, E. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 47, Issue of November 21, 1997 pp. 29426-29429

COMMUNICATION:
Phosphorylation of the N-Formyl Peptide Receptor Is Required for Receptor Internalization but Not Chemotaxis*

(Received for publication, July 15, 1997, and in revised form, September 22, 1997)

Matthew H. Hsu , Stephanie C. Chiang , Richard D. Ye and Eric R. Prossnitz Dagger

From the Department of Immunology, The Scripps Research Institute, La Jolla, California 92037

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENT
REFERENCES


ABSTRACT

The human N-formyl peptide receptor (FPR) is a member of the family of leukocyte, G protein-coupled, chemoattractant receptors. To determine the role(s) of receptor phosphorylation in FPR processing and formylmethionylleucylphenylalanine (fMLF)-mediated chemotaxis, we utilized U937 cells expressing the recombinant wild type receptor and a mutant form of the FPR. This mutant, which lacks all of the serine and threonine residues in the C terminus of the receptor, Delta ST, has recently been shown to produce a receptor capable of fMLF binding and G protein activation but was demonstrated not to undergo fMLF-dependent phosphorylation or desensitization of the calcium mobilization response upon repeated exposure to agonist (Prossnitz, E. R. (1997) J. Biol. Chem. 272, 15213-15219). In this report, we examined the role of receptor phosphorylation in FPR internalization and leukocyte chemotaxis. Whereas the wild type receptor was rapidly internalized upon stimulation, the phosphorylation-deficient mutant was not, remaining entirely on the cell surface. In addition, contrary to the hypothesis that receptor processing and recycling are required for chemotaxis, we found no defect in the ability of the mutant FPR to migrate up a concentration gradient of fMLF. These results indicate that phosphorylation of the FPR is a necessary step in receptor internalization but that receptor phosphorylation, desensitization, and internalization are not required for chemotaxis.


INTRODUCTION

Neutrophils normally exist in a resting state as they circulate though the body. However, upon interaction with small molecules known as chemoattractants, they rapidly respond with endothelial adhesion followed by emigration from the vasculature and chemotaxis to the site of inflammation (1). Chemoattractants activate neutrophils through binding to heptahelical receptors located on the cell surface (2, 3). These receptors activate heterotrimeric GTP-binding proteins (G proteins)1 that initiate numerous elaborate signal transduction cascades, culminating in neutrophil migration and activation. Once at the site of inflammation, neutrophils respond with phagocytosis, superoxide generation, and the release of degradative enzymes (4). One of the most thoroughly studied chemoattractant receptors is the N-formyl peptide receptor (FPR), which recognizes short N-formylated oligopeptides of bacterial or mitochondrial origin (5-7).

Leukocyte chemotaxis has been shown to be dependent on the binding of chemoattractants to their respective receptors (8, 9). Following binding of the ligand and cellular activation, the receptors undergo desensitization and internalization (10, 11). Once internalized, ligand dissociates from the receptor and is degraded, whereupon the receptor is recycled to the cell surface for additional rounds of activation (10). Receptor recycling has been suggested to be essential for sustained cellular responses, such as cell chemotaxis (12, 13). Inhibition of receptor recycling through exposure to wheat germ agglutinin or by neuraminidase treatment was found to block chemotaxis without affecting receptor-mediated superoxide generation or degranulation. Receptor endocytosis was also demonstrated to proceed normally with the internalized receptor accumulating within the cell and not being re-expressed to the cell surface (12, 13). A role for neutral endopeptidase has also been implicated through the use of the inhibitor phosphoramidon (14). Treatment with this inhibitor blocked degradation of the internalized ligand as well as re-expression of the internalized receptor, suggesting that dissociation of the ligand from the receptor and its subsequent hydrolysis are essential for receptor recycling (15). In fact, degradation of internalized ligand was shown to occur at a rate proportional to receptor re-expression, suggesting that the former process may be rate-limiting. Inhibition of receptor recycling through this method specifically blocked chemotaxis but not other neutrophil responses, providing further support for the conclusion that receptor recycling is required for chemotaxis (15).

We have recently shown that phosphorylation of the FPR is an essential step in the functional desensitization of the receptor. In this report, we investigated the role of receptor phosphorylation in the internalization process as a means to examine the role of receptor processing in chemotaxis. Our results demonstrate that although receptor phosphorylation is absolutely essential to receptor desensitization and internalization, neither phosphorylation nor receptor internalization is required for cell chemotaxis.


EXPERIMENTAL PROCEDURES

Materials

The cDNA encoding the FPR was obtained from a human HL-60 granulocyte library as described previously (16). N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys-fluorescein and indo-1AM were obtained from Molecular Probes. fMLF was purchased from Sigma. Carrier-free, acid-free [32P]orthophosphate was from Amersham Corp. Protein A-Sepharose CL-4B beads were obtained from Pharmacia Biotech Inc. Chemotaxis chambers (48-well) were from Neuroprobe with cellulose nitrate filters from Toyo. RPMI was from Whittaker Bioproducts; fetal bovine serum was from HyClone.

Construction and Expression of Site-directed Mutants in U937 Cells

The FPR cDNA was subcloned and mutagenized as described (16, 17). U937 cells were grown in RPMI 1640 supplemented with 2 mM L-glutamine, 100 units/ml penicillin, 100 µg/ml streptomycin, 10 mM HEPES (pH 7.4), and 10% heat-inactivated fetal bovine serum. For transfection, approximately 4 × 106 cells were harvested and resuspended in 400 µl of RPMI 1640 containing 10 mM glucose and 0.1 mM dithiothreitol (18). Linearized DNA (10 µg in a volume of 10 µl) was added to the cells and preincubated for 5 min at room temperature. The cells were then subjected to a 240-V pulse from a 960-microfarad capacitor (resulting in a pulse time constant of approximately 30 ms) and immediately returned to 5-10 ml of culture medium. The following day, G418 was added to a final active concentration of 1 mg/ml. As the selection proceeded, the cells were centrifuged and resuspended in fresh medium (containing G418) at 4-6-day intervals. Cells were cultured at 37 °C in a humidified atmosphere of 6% CO2 and 94% air.

In Vivo Phosphorylation and Immunoprecipitation

Phosphorylation of the FPR was determined as described (19). Briefly, FPR-transfected U937 cells were harvested and washed extensively to remove traces of phosphate. Cells were resuspended in phosphate-free RPMI 1640 containing 1 mCi of carrier-free, acid-free [32P]orthophosphate (10 mCi/ml). Cells were loaded for 3 h at 37 °C and subsequently stimulated with fMLF for 10 min at 37 °C. Cells were lysed by the addition of 0.33 volume of 4 × radioimmune precipitation buffer (40 mM Tris-HCl, pH 7.5, 600 mM NaCl, 4 mM EDTA, 0.4% SDS, 2% deoxycholate, 4% Triton X-100, 4 mM p-nitrophenyl phosphate, 40 mM sodium phosphate, 40 mM NaF, 20 µg/ml soybean trypsin inhibitor, 20 µg/ml leupeptin, 2 mM phenylmethylsulfonyl fluoride, 400 ng/ml aprotinin, and 200 µg/ml pepstatin A). Following lysis, extraction, and removal of insoluble debris, the supernatant was added to 10 mg of Protein A-Sepharose, which had been precoated with 15 µl of a rabbit antiserum directed against the C-terminal 12 amino acids of the FPR, and incubated for 1 h while rotating at 4 °C. The beads were then washed as follows: once with 1 ml of 50 mM Tris-HCl, 500 mM NaCl, 1% Triton X-100, 0.2% SDS, pH 8.0; once with 1 ml of 50 mM Tris-HCl, 500 mM NaCl, 1% Triton X-100, 0.1% SDS, pH 8.0; once with 1 ml of 50 mM Tris-HCl, 500 mM NaCl, pH 8.0; and finally with phosphate-buffered saline. Laemmli sample buffer was added, and the samples were heated at 37 °C for 10 min, followed by electrophoresis on a 12.5% SDS-polyacrylamide gel. Gels were dried, and 32P content was determined with a Molecular Dynamics PhosphorImager.

Desensitization

To assess desensitization, the ability of the cells to respond to ligand with a calcium mobilization response was monitored. For calcium determinations, cells were harvested by centrifugation, washed once with phosphate-buffered saline, and resuspended at 5 × 106 cells/ml in Hanks' buffered saline solution (HBSS). The cells were incubated with 5 µM indo-1AM for 25 min at 37 °C, washed once with HBSS, and resuspended to a concentration of approximately 106 cells/ml in HBSS containing 1.5 mM EGTA, pH 8.0. The elevation of intracellular Ca2+ by fMLF was monitored by continuous fluorescence measurement using an SLM 8000 photon-counting spectrofluorometer (SLM-Aminco) detecting at 400 and 490 nm, respectively, as described (16). The concentration of intracellular Ca2+ was calculated as described (20). For desensitization determinations, cells were first pretreated with 1 µM fMLF, and the response was recorded. The stimulated cells were then removed from the cuvette, washed three times with HBSS at room temperature to remove surface-bound fMLF, and replaced in the cuvette. The response of the washed cells to a second stimulation with 1 µM fMLF was then determined.

Receptor Internalization

Receptor internalization was first determined as the loss of FPR from the cell surface as follows. FPR-transfected U937 cells were harvested, washed, and resuspended in HBSS. Cells were then stimulated with 1 µM fMLF for 10 min at 37 °C and washed three times with HBSS. Remaining cell surface receptors were determined with 10 nM N-formyl-Nle-Leu-Phe-Nle-Tyr-Lys-fluorescein. Following incubation for at least 15 min on ice, cells were analyzed for fluorescent intensity on a FACScan flow cytometer (Becton Dickinson) with dead cells excluded by a gate on forward and side scatter. Nonspecific binding was determined in the presence of 1 µM N-formyl-Met-Leu-Phe. Receptor internalization was determined relative to cells that had not been treated with fMLF.

Internalization was also evaluated as the intracellular accumulation of fML[3H]F as follows. FPR-transfected U937 cells were harvested, washed, and resuspended in HBSS. Cells were incubated with the indicated concentration of fML[3H]F at 37 °C for 60 min. Control cells were incubated on ice (which prevents endocytosis) or with excess unlabeled fMLF to determine nonspecific binding and internalization. After incubation, cell samples were added to 10 volumes of 0.2 M glycine (pH 3.0) containing 0.5 M NaCl for 5 min on ice. This incubation removes ligand bound to the cell surface but has no effect on internalized ligand. Cell samples added to 10 volumes of cold Hanks' buffer (as opposed to pH 3.0 glycine) provided total fML[3H]F associated with the cell, both internal and external. Free ligand was separated from cell-associated ligand by rapid filtration through glass fiber filters followed by three washes with cold dilution buffer. Results are expressed as the percentage of saturably bound fML[3H]F that is internalized and normalized to the amount internalized by the wild type FPR.

Chemotaxis

Cell migration was quantitated with a 48-well chemotaxis chamber (Neuroprobe) using 5.0- or 8.0-µm pore size cellulose nitrate filters (9). Cells and fMLF were prepared in HBSS supplemented with 10 mM HEPES and 1% bovine serum albumin. Chemoattractant was placed in the lower chamber and covered with the cellulose nitrate filter. Cells (4 × 106/ml) were placed in the upper chamber and incubated at 37 °C for 2 h. Following the incubation, the filter was fixed with isopropyl alcohol, stained with hematoxylin, and mounted on a microscope slide. The distance migrated by the cells (in µm) was determined by the leading edge technique (21). For each evaluation, five fields per duplicate filter were measured at 400-fold magnification. The data are presented as the distance migrated by the leading front of the cells in a 2-h span.


RESULTS AND DISCUSSION

It has been well established that G protein-coupled chemoattractant receptors mediate leukocyte chemotaxis (22). The signal transduction cascade initiated by these receptors has also been shown to be essential since treatment of cells with pertussis toxin, which blocks the interaction of Gi proteins with receptors, completely abolishes leukocyte chemotaxis (23-25). Furthermore, actin polymerization has been demonstrated to be essential, since cytochalasins, which block actin polymerization, also abolish chemotaxis (26, 27). Much of the signaling between these two events, however, remains unclear. We have sought to determine the role of receptor processing in these events. Previous experiments have suggested that recycling of chemoattractant receptors is essential for chemotaxis to take place. This conclusion was based on a number of experiments, which correlated a block in the re-expression of internalized chemoattractant receptors with a lack of chemotactic ability despite normal ligand binding, cell activation of superoxide generation and degranulation, and normal receptor internalization (15, 28).

In this study, we have used a unique approach to investigate the role of receptor processing in chemotaxis. We have previously demonstrated that U937 myeloid cells stably transfected with chemoattractant receptors such as the FPR are capable of migrating up a chemotactic gradient (9). This chemotactic response is indistinguishable from the response observed with differentiated U937 cells or neutrophils. To evaluate the role of receptor processing, we compared U937 cells transfected with the wild type FPR to U937 cells transfected with a mutant form of the FPR, Delta ST, in which all of the serine and threonine residues in the C terminus have been converted to alanines and glycines. Fig. 1 demonstrates that, whereas the wild type FPR becomes phosphorylated upon stimulation with fMLF, the Delta ST mutant does not. That the mutant form of the FPR was capable of responding to fMLF was demonstrated by monitoring the mobilization of intracellular calcium. Upon fMLF stimulation, both the wild type and Delta ST mutant underwent similar degrees of calcium mobilization (Fig. 2). This indicated that in the absence of receptor phosphorylation, ligand binding and G protein activation remained intact. We examined desensitization of the fMLF-initiated calcium mobilization response by taking cells that had been exposed to a saturating concentration of fMLF yielding a maximal calcium mobilization response, washing them extensively to remove bound ligand, and determining their responsiveness to a second exposure to fMLF. As expected for the wild type FPR, the amount of calcium mobilization following a second exposure to agonist was minimal (Fig. 2). However, exposing fMLF-treated Delta ST cells to a second dose of ligand yielded a calcium response of the same magnitude as that observed for the first exposure. These results confirm that receptor phosphorylation is an essential step in the functional desensitization of the receptor-mediated response.


Fig. 1. Phosphorylation of the wild type FPR and Delta ST mutant in transfected U937 cells. Cells were loaded with [32P]orthophosphate and treated with 1 µM fMLF for 10 min prior to solubilization and immunoprecipitation of the FPR. Lane 1, vector-transfected U937 cells; lane 2, wild type FPR-transfected U937 cells; lane 3, mutant Delta ST-transfected U937 cells. Data shown are representative of four experiments.

[View Larger Version of this Image (59K GIF file)]



Fig. 2. Desensitization of calcium mobilization of the wild type FPR and Delta ST mutant. FPR desensitization was determined as the decrease in fMLF-stimulated elevation of intracellular calcium in response to a second exposure to fMLF. Cells expressing the wild type (WT) and Delta ST mutant form of the FPR were loaded with indo-1AM and stimulated (pretreated) with 1 µM fMLF. The cells were then washed extensively to remove bound ligand and re-assessed for calcium mobilization in response to a second stimulation with 1 µM fMLF. Data represent mean ± S.E. of four experiments.

[View Larger Version of this Image (15K GIF file)]


To determine what mechanism may underlie this phenomenon, we next evaluated the ability of the receptor to undergo ligand-stimulated internalization. Receptor internalization provides possible mechanisms for desensitization by removing occupied receptors from the cell surface to intracellular endosomes. We initially evaluated receptor endocytosis by determining the amount of receptor remaining on the cell surface following a period of exposure to fMLF. Cell surface receptors were quantitated by flow cytometry using N-formyl-Nle-Leu-Phe-Nle-Tyr-Lys-fluorescein as a specific probe for cell surface-localized FPR. When U937 cells transfected with the wild type FPR were exposed to fMLF for 10 min at 37 °C and assayed for cell surface receptors, they exhibited a 75% decrease in the number of cell surface receptors compared with cells that had not been exposed to fMLF (Fig. 3A). However, when the same comparison was made with U937 cells expressing the Delta ST FPR mutant, which express almost equal numbers of receptors, there was no decrease in the number of cell surface receptors following a pretreatment with fMLF. To confirm that the decrease in cell surface receptors was the result of ligand-mediated receptor internalization, we also measured uptake of tritiated ligand. Increasing concentrations of fML[3H]F were incubated with wild type and mutant cells for 1 h at 37 °C. The cells were then transferred to a low pH buffer, which causes dissociation of ligand bound to the cell surface but has no effect on internalized ligand. Wild type FPR-transfected U937 cells demonstrated significant uptake of fML[3H]F during the course of the assay (Fig. 3B). On the contrary, cells expressing the Delta ST mutant internalized almost no ligand, even at fMLF concentrations 10-fold higher than that required to demonstrate significant uptake with the wild type receptor. These results suggest that receptor phosphorylation is required for internalization as well as desensitization of the FPR and that the two processes may be interdependent.


Fig. 3. Internalization of the wild type FPR is dependent upon receptor phosphorylation. A, cell surface expression of the wild type (WT) and phosphorylation-deficient mutant (Delta ST) of the FPR. Cells were pretreated with 1 µM fMLF (+) or buffer only (-) for 10 min at 37 °C, washed extensively, and incubated with 10 nM N-formyl-Nle-Leu-Phe-Nle-Tyr-Lys-fluorescein prior to analysis by flow cytometry. Mean fluorescent intensity was taken to represent relative cell surface receptor expression. For both wild type and Delta ST cells, receptor expression is expressed relative to the receptor present in untreated cells. B, internalization of the wild type receptor (open circles) and Delta ST mutant FPR (solid circles) was also determined by the uptake of fML[3H]F using a filtration-based method. Following incubation in the indicated concentration of fML[3H]F, remaining surface-bound ligand was removed by a low pH wash so that only internalized ligand was retained on the filter. Data are representative of four experiments.

[View Larger Version of this Image (17K GIF file)]


Having defined a form of the FPR that is capable of binding ligand and initiating signal transduction but incapable of being internalized and thus recycled to the cell surface, we were now able to test the hypothesis that chemotaxis requires recycling of the receptor. Chemotaxis was evaluated using a 48-well chemotaxis chamber with the lower chamber containing chemoattractant separated from the upper chamber containing cells by a 120-µm thick convoluted pore cellulose nitrate filter. This method allows the distinction to be made between simple migration though an "open hole" thin polycarbonate filter and true chemotaxis as revealed with this method. Only myeloid cells are capable of migrating through thick convoluted pore filters whereas many cell types including endothelial cells and fibroblasts, for example, can traverse straight open hole pore filters. The ability of the FPR-transfected U937 cells to undergo chemotaxis in response to a gradient is demonstrated in Table I. Only in the presence of a ligand gradient, with the higher concentration of ligand in the lower chamber, was significant migration into the filter observed. The pattern of migration is consistent with the cells responding in a chemotactic manner, as opposed to a chemokinetic manner, where the presence of ligand in the upper chamber (or both chambers) induces increased random movement of the cells and therefore migration into the filter. Chemotaxis of undifferentiated U937 cells is dependent only upon the introduction of a chemoattractant receptor, such as the FPR, with vector-transfected cells showing no response (Fig. 4). When we tested the Delta ST FPR mutant, we found that the chemotactic potential of this mutant was identical to that of the wild type receptor, demonstrating that receptor processing and recycling are not required for chemotaxis to take place.

Table I. Checkerboard analysis of FPR-transfected U937 cell chemotactic activity

Data are expressed as the distance of migration (in microns) in a 2-h period as described under "Experimental Procedures." Values are means of five measurements on each of duplicate filters and are representative of three experiments.

fMLF in lower chamber fMLF in upper chamber
0 1 nM 10 nM 100 nM

0 0 0 0 0
1 nM 12 0 10 0
10 nM 46 32 11 10
100 nM 53 39 22 0


Fig. 4. Chemotaxis mediated by the wild type FPR is independent of receptor phosphorylation. Receptor-mediated chemotaxis was evaluated using a 48-microwell chemotaxis chamber. Cell migration (in µm) was determined as a function of the concentration of fMLF in the lower chamber after an incubation period of 2 h at 37 °C. down-triangle, wild type FPR-transfected U937 cells; open circle , Delta ST mutant FPR-transfected U937 cells; bullet , vector only-transfected U937 cells. Data are means of duplicate assays, representative of four experiments.

[View Larger Version of this Image (20K GIF file)]


The results of this study have demonstrated for the first time that receptor phosphorylation, internalization, desensitization, and recycling are not required for chemotaxis to occur. Our result is contrary to the conclusions based on inhibitors of receptor recycling, which result in inhibition of neutrophil chemotaxis. It is unclear, however, what additional side effects these inhibitors might have upon cell function. Furthermore, it is possible that only in the presence of internalized receptor is receptor re-expression required for chemotaxis to occur. This would indicate that under normal circumstances, replenishing of cell surface receptors is essential to provide the receptors necessary to propagate migration; however, as our results demonstrate, in the absence of receptor depletion through internalization, chemotaxis can be initiated and continue for a prolonged period of time. This demonstrates that signal transduction mediated by a functional chemoattractant receptor in the absence of receptor desensitization can control the spatial and temporal aspects of the signal transduction cascade that are involved in the remodeling of the actin cytoskeleton that propels the cell forward during chemotaxis. Although receptor desensitization and internalization are not required for chemotaxis, these processes are involved in preventing chronic activation of leukocytes at sites of inflammation. To compensate for the possible lack of receptors during the relatively long periods of chemotaxis, it appears that re-expression of internalized receptors has evolved as a mechanism to ensure sufficient cell surface receptors. In conclusion, although receptor recycling occurs during chemotaxis, it is not an essential component of the chemotactic phenomenon.


FOOTNOTES

*   This research was supported by National Institutes of Health Grants AI36357 (to E. R. P.) and AI33503 (to R. D. Y.) and by a grant-in-aid from the American Heart Association (to E. R. P.). This is Publication 10987-IMM from the Department of Immunology, the Scripps Research Institute.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    To whom correspondence and reprint requests should be addressed: Dept. of Immunology, IMM25, The Scripps Research Inst., 10550 N. Torrey Pines Rd., La Jolla CA 92037. Tel.: 619-784-8549; Fax: 619-784-8476; E-mail: epross{at}scripps.edu.
1   The abbreviations used are: G protein, guanine nucleotide-binding regulatory protein; FPR, N-formyl peptide receptor; Nle, norleucine; fMLF, N-formyl-methionyl-leucyl-phenylalanine; HBSS, Hanks' buffered saline solution.

ACKNOWLEDGEMENT

We thank Dr. Richard Kew for expertise in analyzing chemotaxis results.


REFERENCES

  1. Zigmond, S. H. (1989) Curr. Opin. Cell Biol. 1, 80-86 [CrossRef][Medline] [Order article via Infotrieve]
  2. Murphy, P. M. (1994) Annu. Rev. Immunol. 12, 593-633 [CrossRef][Medline] [Order article via Infotrieve]
  3. Ye, R. D., and Boulay, F. (1997) Adv. Pharmacol. 39, 221-289
  4. Snyderman, R., and Uhing, R. J. (1992) in Inflammation: Basic Principles and Clinical Correlates (Gallin, J. I., Goldstein, I. M., and Snyderman, R., eds), 2nd Ed., pp. 421-439, Raven Press, New York
  5. Boulay, F., Tardif, M., Brouchon, L., and Vignais, P. (1990) Biochem. Biophys. Res. Commun. 168, 1103-1109 [CrossRef][Medline] [Order article via Infotrieve]
  6. Prossnitz, E. R., and Ye, R. D. (1997) Pharmacol. Ther. 74, 73-102 [CrossRef][Medline] [Order article via Infotrieve]
  7. Schiffmann, E., Showell, H. V., Corcoran, B. A., Ward, P. A., Smith, E., and Becker, E. L. (1975) J. Immunol. 114, 1831-1837 [Abstract/Free Full Text]
  8. Zigmond, S. H. (1989) Am. J. Respir. Cell Mol. Biol. 1, 451-453
  9. Kew, R. R., Peng, T., DiMartino, S. J., Madhavan, D., Weinman, S. J., Cheng, D., and Prossnitz, E. R. (1997) J. Leukocyte Biol. 61, 329-337 [Abstract]
  10. van Epps, D. E., Simpson, S., Bender, J. G., and Chenoweth, D. E. (1990) J. Immunol. 144, 1062-1068 [Abstract]
  11. Wilde, M. W., Carlson, K. E., Manning, D. R., and Zigmond, S. H. (1989) J. Biol. Chem. 264, 190-196 [Abstract/Free Full Text]
  12. Perez, H. D., Elfman, F., Marder, S., Lobo, E., and Ives, H. E. (1989) J. Clin. Invest. 83, 1963-1970
  13. Perez, H. D., Ong, R., Khanna, K., Banda, D., and Goldstein, I. M. (1982) J. Immunol. 129, 2718-2724 [Abstract]
  14. Painter, R. G., Dukes, R., Sullivan, J., Carter, R., Erdos, E. G., and Johnson, A. R. (1988) J. Biol. Chem. 263, 9456-9461 [Abstract/Free Full Text]
  15. Painter, R. G., and Aiken, M. L. (1995) J. Leukocyte Biol. 58, 468-476 [Abstract]
  16. Prossnitz, E. R., Quehenberger, O., Cochrane, C. G., and Ye, R. D. (1991) Biochem. Biophys. Res. Commun. 179, 471-476 [CrossRef][Medline] [Order article via Infotrieve]
  17. Prossnitz, E. R., Quehenberger, O., Cochrane, C. G., and Ye, R. D. (1993) Biochem. J. 294, 581-587
  18. Prossnitz, E. R., Quehenberger, O., Cochrane, C. G., and Ye, R. D. (1993) J. Immunol. 151, 5704-5715 [Abstract]
  19. Prossnitz, E. R. (1997) J. Biol. Chem. 272, 15213-15219 [Abstract/Free Full Text]
  20. Cobbold, P. H., and Rink, T. J. (1987) Biochem. J. 248, 313-328 [Medline] [Order article via Infotrieve]
  21. Zigmond, S. H., and Hirsch, J. G. (1973) J. Exp. Med. 137, 387-410 [Abstract]
  22. Snyderman, R., Smith, C. D., and Verghese, M. W. (1986) J. Leukocyte Biol. 40, 785-800 [Abstract]
  23. Lad, P. M., Olson, C. V., and Grewal, I. S. (1986) FEBS Lett. 200, 91-96 [CrossRef][Medline] [Order article via Infotrieve]
  24. Becker, E. L., Kermode, J. C., Naccache, P. H., Yassin, R., Marsh, M. L., Munoz, J. J., and Sha'afi, R. I. (1985) J. Cell Biol. 100, 1641-1646 [Abstract/Free Full Text]
  25. Spangrude, G. J., Sacchi, F., Hill, H. R., Van Epps, D. E., and Daynes, R. A. (1985) J. Immunol. 135, 4135-4143 [Abstract]
  26. Pham Huu, T. (1979) Biomedicine (Paris) 30, 121-124
  27. Becker, E. L., Davis, A. T., Estensen, R. D., and Quie, P. G. (1972) J. Immunol. 108, 396-402 [Abstract/Free Full Text]
  28. Perez, H. D., Elfman, F., Lobo, E., Sklar, L., Chenoweth, D., and Hooper, C. (1986) J. Immunol. 136, 1803-1812 [Abstract]

Volume 272, Number 47, Issue of November 21, 1997 pp. 29426-29429
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
B. A. Babbin, A. J. Jesaitis, A. I. Ivanov, D. Kelly, M. Laukoetter, P. Nava, C. A. Parkos, and A. Nusrat
Formyl Peptide Receptor-1 Activation Enhances Intestinal Epithelial Cell Restitution through Phosphatidylinositol 3-Kinase-Dependent Activation of Rac1 and Cdc42
J. Immunol., December 15, 2007; 179(12): 8112 - 8121.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Chigaev, A. Waller, G. J. Zwartz, T. Buranda, and L. A. Sklar
Regulation of Cell Adhesion by Affinity and Conformational Unbending of {alpha}4beta1 Integrin
J. Immunol., June 1, 2007; 178(11): 6828 - 6839.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. Xue, G. Hsieh, M. A. Raymond-Stintz, J. Pfeiffer, D. Roberts, S. L. Steinberg, J. M. Oliver, E. R. Prossnitz, D. S. Lidke, and B. S. Wilson
Activated N-Formyl Peptide Receptor and High-Affinity IgE Receptor Occupy Common Domains for Signaling and Internalization
Mol. Biol. Cell, April 1, 2007; 18(4): 1410 - 1420.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Sai, G. Walker, J. Wikswo, and A. Richmond
The IL Sequence in the LLKIL Motif in CXCR2 Is Required for Full Ligand-induced Activation of Erk, Akt, and Chemotaxis in HL60 Cells
J. Biol. Chem., November 24, 2006; 281(47): 35931 - 35941.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Balabanian, B. Lagane, J. L. Pablos, L. Laurent, T. Planchenault, O. Verola, C. Lebbe, D. Kerob, A. Dupuy, O. Hermine, et al.
WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12
Blood, March 15, 2005; 105(6): 2449 - 2457.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J. Sai, G.-H. Fan, D. Wang, and A. Richmond
The C-terminal domain LLKIL motif of CXCR2 is required for ligand-mediated polarization of early signals during chemotaxis
J. Cell Sci., November 1, 2004; 117(23): 5489 - 5496.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Xue, C. M. Vines, T. Buranda, D. F. Cimino, T. A. Bennett, and E. R. Prossnitz
N-Formyl Peptide Receptors Cluster in an Active Raft-associated State Prior to Phosphorylation
J. Biol. Chem., October 22, 2004; 279(43): 45175 - 45184.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Chigaev, G. J. Zwartz, T. Buranda, B. S. Edwards, E. R. Prossnitz, and L. A. Sklar
Conformational Regulation of {alpha}4{beta}1-Integrin Affinity by Reducing Agents: "INSIDE-OUT" SIGNALING IS INDEPENDENT OF AND ADDITIVE TO REDUCTION-REGULATED INTEGRIN ACTIVATION
J. Biol. Chem., July 30, 2004; 279(31): 32435 - 32443.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. M. Revankar, C. M. Vines, D. F. Cimino, and E. R. Prossnitz
Arrestins Block G Protein-coupled Receptor-mediated Apoptosis
J. Biol. Chem., June 4, 2004; 279(23): 24578 - 24584.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Kavelaars, A. Vroon, R. P. Raatgever, A. M. Fong, R. T. Premont, D. D. Patel, R. J. Lefkowitz, and C. J. Heijnen
Increased Acute Inflammation, Leukotriene B4-Induced Chemotaxis, and Signaling in Mice Deficient for G Protein-Coupled Receptor Kinase 6
J. Immunol., December 1, 2003; 171(11): 6128 - 6134.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. M. Richardson, R. J. Marjoram, L. S. Barak, and R. Snyderman
Role of the Cytoplasmic Tails of CXCR1 and CXCR2 in Mediating Leukocyte Migration, Activation, and Regulation
J. Immunol., March 15, 2003; 170(6): 2904 - 2911.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. He, D. D. Browning, and R. D. Ye
Differential Roles of the NPXXY Motif in Formyl Peptide Receptor Signaling
J. Immunol., March 15, 2001; 166(6): 4099 - 4105.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
H. Miettinen, J. Gripentrog, and A. Jesaitis
Chemotaxis of chinese hamster ovary cells expressing the human neutrophil formyl peptide receptor: role of signal transduction molecules and alpha5beta1 integrin
J. Cell Sci., June 8, 2000; 111(14): 1921 - 1928.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
T. Christophe, M.-J. Rabiet, M. Tardif, M.-D. Milcent, and F. Boulay
Human Complement 5a (C5a) Anaphylatoxin Receptor (CD88) Phosphorylation Sites and Their Specific Role in Receptor Phosphorylation and Attenuation of G Protein-mediated Responses. DESENSITIZATION OF C5a RECEPTOR CONTROLS SUPEROXIDE PRODUCTION BUT NOT RECEPTOR SEQUESTRATION IN HL-60 CELLS
J. Biol. Chem., January 21, 2000; 275(3): 1656 - 1664.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Cottin, A. Van Linden, and D. W. H. Riches
Phosphorylation of Tumor Necrosis Factor Receptor CD120a (p55) by p42mapk/erk2 Induces Changes in Its Subcellular Localization
J. Biol. Chem., November 12, 1999; 274(46): 32975 - 32987.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. C. Maestes, R. M. Potter, and E. R. Prossnitz
Differential Phosphorylation Paradigms Dictate Desensitization and Internalization of the N-Formyl Peptide Receptor
J. Biol. Chem., October 15, 1999; 274(42): 29791 - 29795.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. R. Sambrano and S. R. Coughlin
The Carboxyl Tail of Protease-activated Receptor-1 Is Required for Chemotaxis. CORRELATION OF SIGNAL TERMINATION AND DIRECTIONAL MIGRATION
J. Biol. Chem., July 16, 1999; 274(29): 20178 - 20184.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
N. Malecz, T. Bambino, M. Bencsik, and R. A. Nissenson
Identification of Phosphorylation Sites in the G Protein-Coupled Receptor for Parathyroid Hormone. Receptor Phosphorylation Is Not Required for Agonist-Induced Internalization
Mol. Endocrinol., December 1, 1998; 12(12): 1846 - 1856.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
W. G. Thomas, T. J. Motel, C. E. Kule, V. Karoor, and K. M. Baker
Phosphorylation of the Angiotensin II (AT1A) Receptor Carboxyl Terminus: A Role in Receptor Endocytosis
Mol. Endocrinol., October 1, 1998; 12(10): 1513 - 1524.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
T. A. Bennett, D. C. Maestas, and E. R. Prossnitz
Arrestin Binding to the G Protein-coupled N-Formyl Peptide Receptor Is Regulated by the Conserved "DRY" Sequence
J. Biol. Chem., August 4, 2000; 275(32): 24590 - 24594.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Christophe, A. Karlsson, C. Dugave, M.-J. Rabiet, F. Boulay, and C. Dahlgren
The Synthetic Peptide Trp-Lys-Tyr-Met-Val-Met-NH2 Specifically Activates Neutrophils through FPRL1/Lipoxin A4 Receptors and Is an Agonist for the Orphan Monocyte-expressed Chemoattractant Receptor FPRL2
J. Biol. Chem., June 8, 2001; 276(24): 21585 - 21593.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Kraft, H. Olbrich, I. Majoul, M. Mack, A. Proudfoot, and M. Oppermann
Characterization of Sequence Determinants within the Carboxyl-terminal Domain of Chemokine Receptor CCR5 That Regulate Signaling and Receptor Internalization
J. Biol. Chem., September 7, 2001; 276(37): 34408 - 34418.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. A. Bennett, T. D. Foutz, V. V. Gurevich, L. A. Sklar, and E. R. Prossnitz
Partial Phosphorylation of the N-Formyl Peptide Receptor Inhibits G Protein Association Independent of Arrestin Binding
J. Biol. Chem., December 21, 2001; 276(52): 49195 - 49203.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsu, M. H.
Right arrow Articles by Prossnitz, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsu, M. H.
Right arrow Articles by Prossnitz, E. R.